M. Coniglio et al., ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES ARE NOT AN UNCOMMON FEATURE IN RETINAL VENOUS OCCLUSIONS, Thrombosis research, 83(2), 1996, pp. 183-188
The Primary Antiphospholipid Protein Syndrome (PAPS) is characterised
by venous and/or arterial thromboses and recurrent foetal loss, in the
presence of the Lupus Anticoagulant (LA), elevated antibodies to card
iolipin (ACA) or both. This investigation evaluates the relation betwe
en the PAPS and Retinal Vein Occlusion (RVO). Forty-eight consecutive
patients with RVO were screened for ACA and LA. PAPS was present in 16
(33%) of the patients. Our results suggest that testing Antiphospholi
pid-Protein Antibodies (APA) may be useful in these patients, together
with the assessment of other vascular risk factors.